Hoon-Kyo Kim

518 total citations
33 papers, 399 citations indexed

About

Hoon-Kyo Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hoon-Kyo Kim has authored 33 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 6 papers in Surgery. Recurrent topics in Hoon-Kyo Kim's work include Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Treatment and Pharmacology (5 papers). Hoon-Kyo Kim is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Treatment and Pharmacology (5 papers). Hoon-Kyo Kim collaborates with scholars based in South Korea, United States and China. Hoon-Kyo Kim's co-authors include Dorothy Keefe, Shiying Yu, Alexandre Chan, Thomas Burke, Myung Ah Lee, Ruey Kuen Hsieh, Byoung Yong Shim, Baohui Han, Sedat Altuǧ and Xin Wang and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Medicine.

In The Last Decade

Hoon-Kyo Kim

32 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hoon-Kyo Kim South Korea 12 187 171 142 56 54 33 399
N. Anderson United States 10 240 1.3× 98 0.6× 151 1.1× 32 0.6× 102 1.9× 19 473
Felicitas Lenz Germany 6 196 1.0× 161 0.9× 135 1.0× 34 0.6× 51 0.9× 8 421
Francesco Agustoni Italy 12 212 1.1× 171 1.0× 108 0.8× 86 1.5× 90 1.7× 54 499
C Frank United States 8 123 0.7× 209 1.2× 166 1.2× 61 1.1× 49 0.9× 10 450
M. González‐Barón Spain 9 213 1.1× 67 0.4× 75 0.5× 60 1.1× 35 0.6× 20 316
Viola Barucca Italy 13 343 1.8× 111 0.6× 115 0.8× 19 0.3× 90 1.7× 19 496
Xiao‐Jiang Chen China 13 156 0.8× 170 1.0× 117 0.8× 17 0.3× 44 0.8× 28 368
Shinya Kajiura Japan 12 239 1.3× 215 1.3× 150 1.1× 11 0.2× 60 1.1× 72 468
Piotr Spychalski Poland 10 127 0.7× 106 0.6× 94 0.7× 19 0.3× 62 1.1× 34 324
Thomas McFarlane Canada 9 125 0.7× 56 0.3× 108 0.8× 40 0.7× 33 0.6× 19 303

Countries citing papers authored by Hoon-Kyo Kim

Since Specialization
Citations

This map shows the geographic impact of Hoon-Kyo Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoon-Kyo Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoon-Kyo Kim more than expected).

Fields of papers citing papers by Hoon-Kyo Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoon-Kyo Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoon-Kyo Kim. The network helps show where Hoon-Kyo Kim may publish in the future.

Co-authorship network of co-authors of Hoon-Kyo Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hoon-Kyo Kim. A scholar is included among the top collaborators of Hoon-Kyo Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoon-Kyo Kim. Hoon-Kyo Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jeeyun, Seung Kim, Do‐Hyun Nam, et al.. (2019). First-in-human phase I trial of anti-hepatocyte growth factor (HGF) antibody (YYB101) in refractory solid tumor patients: Integrative pathologic-genomic analysis and the final results.. Journal of Clinical Oncology. 37(15_suppl). 3104–3104. 2 indexed citations
2.
3.
An, Ho Jung, Il‐Kyu Kim, Jung Eun Lee, et al.. (2015). Nebulized Morphine for Intractable Cough in Advanced Cancer: Two Case Reports. Journal of Palliative Medicine. 18(3). 278–281. 2 indexed citations
4.
Keefe, Dorothy, Alexandre Chan, Hoon-Kyo Kim, et al.. (2014). Rationale and design of the Pan Australasian chemotherapy-induced emesis burden of illness study. Supportive Care in Cancer. 23(1). 253–261. 7 indexed citations
5.
Hsieh, Ruey Kuen, Alexandre Chan, Hoon-Kyo Kim, et al.. (2014). Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries. Supportive Care in Cancer. 23(1). 263–272. 46 indexed citations
6.
Kim, Hoon-Kyo, Ruey-Kuen Hsieh, Alexandre Chan, et al.. (2014). Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice. Supportive Care in Cancer. 23(1). 293–300. 16 indexed citations
7.
Lee, Jeong Won, Jong Hoon Lee, Hoon-Kyo Kim, et al.. (2014). The Efficacy of External Beam Radiotherapy for Airway Obstruction in Lung Cancer Patients. Cancer Research and Treatment. 47(2). 189–196. 17 indexed citations
8.
9.
10.
Yoo, Jinyoung, et al.. (2008). Protein Expression and Gene Amplification of Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer: Correlation with the Response to Gefitinib Therapy. The Korean Journal of Pathology. 1–8. 1 indexed citations
11.
Seo, Kyung Jin, et al.. (2008). An Analysis of HER-2/neu, ERCC1, and GST-pi in Advanced Non-Small Cell Lung Cancer Patients Who are Treated with Platinum-based Chemotherapy. Journal of Pathology and Translational Medicine. 42(6). 327–334. 1 indexed citations
12.
Kim, Yeon‐Sil, Bum‐Soo Kim, Yeonsoo Lee, et al.. (2008). Radiation Therapy Combined with (or without) Cisplatin-based Chemotherapy for Patients with Nasopharyngeal Cancer: 15-years Experience of a Single Institution in Korea. Cancer Research and Treatment. 40(4). 155–155. 22 indexed citations
13.
Song, Do Seon, Chang Dong Yeo, Sheng Sun, et al.. (2007). The prevalence of fatigue in cancer patients at St. Vincent's hospital. The Korean Journal of Internal Medicine. 73(5). 512–518. 6 indexed citations
14.
Kim, Hoon-Kyo, et al.. (2007). Sequential Responses of Adenocarcinoma of the Lung to Erlotinib after Gefitinib in Never Smoker Korean Woman. Cancer Research and Treatment. 39(1). 37–37. 1 indexed citations
15.
Shim, Byoung Yong, Chi Hong Kim, Eun Jung Hong, et al.. (2005). The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m2) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated with Platinum-based Chemotherapy. Cancer Research and Treatment. 37(6). 339–339. 5 indexed citations
16.
Shim, Byoung Yong, Kang‐Moon Lee, Hyeon‐Min Cho, et al.. (2005). Oxaliplatin/5-FU without Leucovorin Chemotherapy in Metastatic Colorectal Cancer. Cancer Research and Treatment. 37(4). 212–212. 4 indexed citations
17.
Shim, Byoungyong, et al.. (2004). DNR (Do-Not-Resuscitate) Order for Terminal Cancer Patients at Hospice Ward. The Korean Journal of Hospice and Palliative Care. 7(2). 232–237. 6 indexed citations
18.
Park, Cho‐Hyun, Ji‐Youn Han, In‐Sik Chung, et al.. (2000). The Effect of Screening of Stomach Cancer on Stage Shift. Journal of Preventive Medicine and Public Health. 33(1). 25–30. 2 indexed citations
19.
Moon, Young‐Wan, Robert J. Weil, Svetlana Pack, et al.. (2000). Missense Mutation of the MET Gene Detected in Human Glioma. Modern Pathology. 13(9). 973–977. 18 indexed citations
20.
Kim, Hoon-Kyo, et al.. (1998). Guidelines on Adverse Drug Reaction Reporting. 6(2). 109–109. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Anderson Breakdown of academic impact, for papers by Felicitas Lenz Breakdown of academic impact, for papers by Francesco Agustoni Breakdown of academic impact, for papers by C Frank Breakdown of academic impact, for papers by M. González‐Barón Breakdown of academic impact, for papers by Viola Barucca Breakdown of academic impact, for papers by Xiao‐Jiang Chen Breakdown of academic impact, for papers by Shinya Kajiura Breakdown of academic impact, for papers by Piotr Spychalski Breakdown of academic impact, for papers by Thomas McFarlane
Rankless by CCL
2026